Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, FARMERS & MERCHANTS BANCORP INC insiders sold a net $6.3M of stock across 104 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
73 earlier Form 4 trades (code P or S) here by this insider (73 sales), the last on Aug 17, 2026.
The trade is 4.9% of the 49,148 shares held after it.
1 other insider sold within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Briggs Andrew J sold about $84.2K of FMAO on Aug 18, 2026; 1 other insider sold within 30 days and 70 funds added in the latest 13F quarter.
72 earlier Form 4 trades (code P or S) here by this insider (72 sales), the last on Aug 14, 2026.
The trade is 5.8% of the 51,550 shares held after it.
1 other insider sold within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Briggs Andrew J sold about $105.3K of FMAO on Aug 17, 2026; 1 other insider sold within 30 days and 70 funds added in the latest 13F quarter.
71 earlier Form 4 trades (code P or S) here by this insider (71 sales), the last on Aug 13, 2026.
The trade is 5.5% of the 54,550 shares held after it.
1 other insider sold within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Briggs Andrew J sold about $106.1K of FMAO on Aug 14, 2026; 1 other insider sold within 30 days and 70 funds added in the latest 13F quarter.
70 earlier Form 4 trades (code P or S) here by this insider (70 sales), the last on Aug 12, 2026.
The trade is 5.2% of the 57,550 shares held after it.
1 other insider sold within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Briggs Andrew J sold about $105.6K of FMAO on Aug 13, 2026; 1 other insider sold within 30 days and 70 funds added in the latest 13F quarter.
69 earlier Form 4 trades (code P or S) here by this insider (69 sales), the last on Aug 11, 2026.
The trade is 5.0% of the 60,550 shares held after it.
1 other insider sold within 30 days.
70 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Briggs Andrew J sold about $104.8K of FMAO on Aug 12, 2026; 1 other insider sold within 30 days and 70 funds added in the latest 13F quarter.
104 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
FMAO planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Briggs Andrew J
Filed 2026-08-17
$189.7K
Briggs Andrew J
Filed 2026-08-10
$518.1K
Briggs Andrew J
Filed 2026-08-03
$505.4K
Briggs Andrew J
Filed 2026-07-27
$464.7K
Briggs Andrew J
Filed 2026-07-20
$458.6K
FMAO mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Regional Bank Fund
$5.1M position · as of 2026-07-31
0.5%
First Trust NASDAQ ABA Community Bank Index Fund
$148.4K position · as of 2026-06-30
0.2%
Unusual Whales Subversive Republican Trading ETF
$125.9K position · as of 2026-06-30
0.1%
Innovator U.S. Small Cap Managed 10 Buffer ETF
$13.4K position · as of 2026-07-31
0.1%
iShares Micro-Cap ETF
$1.4M position · as of 2026-06-30
0.1%
PGIM Quant Solutions Small-Cap Value Fund
$226.8K position · as of 2026-07-31
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Lars B. Eller
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$910.2K
$1.0M
$394.0K
-1%
n/a
2023
$701.9K
$666.8K
$337.7K
-20%
n/a
2022
$753.6K
$708.9K
$380.6K
-15%
n/a
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $6.3M sold by insiders over 180 days, 70 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $1.2M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$41.5M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM FMAO
FY Dec 2025
$35.0M
FY Dec 2024
$30.6M
FY Dec 2023
$11.2M
FY Dec 2022
$38.1M
FY Dec 2021
$32.8M
Jun 2026
$10.6M
Mar 2026
$7.0M
Dec 2025
$13.2M
Sep 2025
$10.7M
Jun 2025
$385.0K
Mar 2025
$10.6M
Dec 2024
$1.9M
Sep 2024
$18.3M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity FMAO
FY Dec 2025
+9.4%
FY Dec 2024
+8.0%
FY Dec 2023
+7.4%
FY Dec 2022
+10.9%
FY Dec 2021
+8.6%
Jun 2026
+10.9%
Mar 2026
+10.0%
Dec 2025
+9.4%
Sep 2025
+9.2%
Jun 2025
+8.8%
Mar 2025
+8.3%
Dec 2024
+8.0%
Sep 2024
+7.2%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets FMAO
FY Dec 2025
+1.0%
FY Dec 2024
+0.8%
FY Dec 2023
+0.7%
FY Dec 2022
+1.2%
FY Dec 2021
+1.0%
Jun 2026
+1.2%
Mar 2026
+1.0%
Dec 2025
+1.0%
Sep 2025
+0.9%
Jun 2025
+0.9%
Mar 2025
+0.8%
Dec 2024
+0.8%
Sep 2024
+0.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.65x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing FMAO
FY Dec 2025
10.21x
FY Dec 2024
15.50x
FY Dec 2023
14.85x
FY Dec 2022
11.05x
FY Dec 2021
16.42x
Jun 2026
10.51x
Mar 2026
9.84x
Dec 2025
10.21x
Sep 2025
10.78x
Jun 2025
11.70x
Mar 2025
11.84x
Dec 2024
15.50x
Sep 2024
16.26x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value FMAO
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+8.2%
TTM free cash flow over market value at close 2026-10-26
FCF yield FMAO
FY Dec 2025
+10.3%
FY Dec 2024
+7.6%
FY Dec 2023
+3.3%
FY Dec 2022
+10.3%
FY Dec 2021
+7.6%
Jun 2026
+9.9%
Mar 2026
+8.9%
Dec 2025
+10.3%
Sep 2025
+6.9%
Jun 2025
+9.0%
Mar 2025
+12.2%
Dec 2024
+7.6%
Sep 2024
+9.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.36x
P/E over trailing EPS growth of 35%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing FMAO
FY Dec 2025
0.37x
FY Dec 2024
1.13x
FY Dec 2023
n/a
FY Dec 2022
0.48x
FY Dec 2021
n/a
Jun 2026
0.30x
Mar 2026
0.34x
Dec 2025
0.37x
Sep 2025
0.30x
Jun 2025
0.31x
Mar 2025
0.44x
Dec 2024
1.13x
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
FMAO ranks highest on risk and compliance (64th percentile) and profitability (56th), and lowest on insider conviction (28th), among Banks peers.
Profitability
56
Inputs
Return on equity+10.9% · 55 pct, sector of 327
Return on assets+1.2% · 57 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$6.3M · 9 pct, sector of 274
Insider buyers, 180d1 · 46 pct, sector of 274
Institutional and government
53
Inputs
Funds adding, latest quarter70 · 33 pct, sector of 257
Congress net buyers, 365d1 · 72 pct, sector of 33
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
64
Inputs
Short interest, % of float+1.8% · 64 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Growth, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
FMAO filings, in plain words
Are Farmers & Merchants Bancorp insiders buying or selling FMAO?
In the 180 days to 2026-10-28, Farmers & Merchants Bancorp insiders were net sellers, a net $6.3M: $10.3K of purchases and $6.3M of sales reported on Form 4, by 1 buyer and 2 sellers.
Have members of Congress traded FMAO?
Yes. In the year to 2026-10-28, 1 House member disclosed buying FMAO and 0 House members disclosed selling it; the latest on record is a purchase by Robert E. Latta dated 2026-07-20.
Are there planned insider sales of FMAO?
Yes. 3 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.2M of stock; the latest, by Briggs Andrew J, was filed 2026-08-17.
Read the full summary
In the 180 days to 2026-10-28, Farmers & Merchants Bancorp insiders were net sellers of FMAO, a net $6.3M across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Sales outweighed purchases more than tenfold by value. None of the 70 insider sales was flagged as made under a Rule 10b5-1 plan. In the year to 2026-10-28, 1 member of Congress disclosed buying FMAO and 0 members disclosed selling it; the latest on record is a purchase by Robert E. Latta dated 2026-07-20. Insiders filed 3 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.2M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.